Efficacy and safety of sclerotherapy with polidocanol in children with internal hemorrhoids.
child
hemorrhoid
polidocanol
sclerotherapy
Journal
Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
revised:
23
09
2020
received:
04
05
2020
accepted:
07
10
2020
pubmed:
13
10
2020
medline:
19
8
2021
entrez:
12
10
2020
Statut:
ppublish
Résumé
Hemorrhoids are an extremely rare condition in children, and data on its incidence and treatment in the pediatric population remains scarce. We retrospectively reviewed children who underwent sclerotherapy for internal hemorrhoids, and analyzed patients' characteristics and outcomes. A total of 14 pediatric patients who underwent sclerotherapy were included. Patients' ages and the required amount of polidocanol, depending on the grade of hemorrhoids, and the correlation between age and volume of sclerosant, were statistically analyzed. Patients had a male predominance with a ratio of 2.5:1 (grade 2:6 patients, grade 3:8 patients). Four children had underlying conditions including portal hypertension and Klippel-Trenaunay syndrome. Of the 14 patients, 43% had constipation requiring medication or enema. Only one minor complication, a perianal ulceration, was found to be associated with sclerotherapy. Patients with grade 3 hemorrhoids required a significantly larger amount of polidocanol than those with grade 2 hemorrhoids. Two patients with grade 3 hemorrhoids required a second session of treatment for recurrence. The success rate of sclerotherapy with polidocanol was 86%. Sclerotherapy with polidocanol is a safe, effective, and less invasive treatment option for internal hemorrhoids in children. Further studies are needed to investigate this treatment approach.
Sections du résumé
BACKGROUND
BACKGROUND
Hemorrhoids are an extremely rare condition in children, and data on its incidence and treatment in the pediatric population remains scarce. We retrospectively reviewed children who underwent sclerotherapy for internal hemorrhoids, and analyzed patients' characteristics and outcomes.
METHODS
METHODS
A total of 14 pediatric patients who underwent sclerotherapy were included. Patients' ages and the required amount of polidocanol, depending on the grade of hemorrhoids, and the correlation between age and volume of sclerosant, were statistically analyzed.
RESULTS
RESULTS
Patients had a male predominance with a ratio of 2.5:1 (grade 2:6 patients, grade 3:8 patients). Four children had underlying conditions including portal hypertension and Klippel-Trenaunay syndrome. Of the 14 patients, 43% had constipation requiring medication or enema. Only one minor complication, a perianal ulceration, was found to be associated with sclerotherapy. Patients with grade 3 hemorrhoids required a significantly larger amount of polidocanol than those with grade 2 hemorrhoids. Two patients with grade 3 hemorrhoids required a second session of treatment for recurrence. The success rate of sclerotherapy with polidocanol was 86%.
CONCLUSIONS
CONCLUSIONS
Sclerotherapy with polidocanol is a safe, effective, and less invasive treatment option for internal hemorrhoids in children. Further studies are needed to investigate this treatment approach.
Substances chimiques
Sclerosing Solutions
0
Polidocanol
0AWH8BFG9A
Polyethylene Glycols
3WJQ0SDW1A
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
813-817Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 Japan Pediatric Society.
Références
Johanson JF, Sonnenberg A. The prevalence of hemorrhoids and chronic constipation. An epidemiologic study. Gastroenterology. 1990; 98: 380-6.
Hachiro Y, Kunimoto M, Abe T, Kitada M, Ebisawa Y. Aluminum potassium sulfate and tannic acid (ALTA) injection as the mainstay of treatment for internal hemorrhoids. Surg. Today. 2011; 41: 806-9.
Miyamoto H, Hada T, Ishiyama G, Ono Y, Watanabe H. Aluminum potassium sulfate and tannic acid sclerotherapy for Goligher Grades II and III hemorrhoids: Results from a multicenter study. World J. Hepatol. 2016; 8: 844-9.
Moser KH, Mosch C, Walgenbach M et al. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: A randomised, controlled, single-blind, multicentre trial. Int. J. Colorectal Dis. 2013; 28(10): 1439-47.
Yuksel BC, Armagan H, Berkem H, Yildiz Y, Ozel H, Hengirmen S. Conservative management of hemorrhoids: A comparison of venotonic flavonoid micronized purified flavonoid fraction (MPFF) and sclerotherapy. Surg. Today. 2008; 38(2): 123-9.
Coran AG. Pediatric Surgery, 7th edn. Saunders Elsevier, Philadelphia, 2012; 1319.
O'Neil JA. Pediatric Surgery, 5th edn. Mosby, St Louis, 1998; 1456.
Heaton ND, Davenport M, Howard ER. Symptomatic hemorrhoids and anorectal varices in children with portal hypertension. J. Pediatr. Surg. 1992; 27: 833-5.
Heaton ND, Davenport M, Howard ER. Incidence of haemorrhoids and anorectal varices in children with portal hypertension. Br. J. Surg. 1993; 80: 616-8.
Jc G. Surgery of the anus, rectum and colon, 3rd edn. Balliere, Tindall and Cassell, London, 1976: 118.
Stites T, Lund DP. Common anorectal problems. Semin. Pediatr. Surg. 2007; 16: 71-8.
Brisinda G, Civello IM, Maria G. Haemorrhoidectomy: Painful choice. Lancet. 2003; 355: 2253.
Al-Ghnaniem R, Leather AJ, Rennie JA. Survey of methods of treatment of haemorrhoids and complications of injection sclerotherapy. Ann. R. Coll. Surg. Engl. 2001; 83: 325-8.
Isshi KYM, Suzuki H. Flexiblescopic hemorrhoidal sclerotherapy and flexiblescopic hemorrhoidal ligation and sclerotherapy for internal hemorrhoids. J. Jpn. Soc. Coloproctol. 1999; 51(10): 1065-69.
Arabi Y, Alexander-Williams J, Keighley MR. Anal pressures in hemorrhoids and anal fissure. Am. J. Surg. 1977; 134: 608-10.
Akerud L. Sclerotherapy of haemorrhoids: a prospective randomised trial of polidocanol and phenol in oil. Coloproctology. 1995; 17: 73-86.
Miyamoto H, Asanoma M, Miyamoto H, Shimada M. ALTA injection sclerosing therapy:non-excisional treatment of internal hemorrhoids. Hepatogastroenterology. 2012; 59: 77-80.
Kunimoto MAT, Hachiro Y, Tsuruma T. Treatment of rectal ulcer complicating sclerosing therapy for internal hemorrhoids with Aluminum potassium sulfate tannic acid (ALTA). J. Jpn. Soc. Coloproctology. 2007; 60: 327-32.
Ohsawa TTY, Chika N, Yamamoto A, Ishibashi K, Ishida H. A case of ALTA therapy for the hemorrhoidal bleeding of junior high school boy with severe anemia. Rynsho. Komonbyo. Gaku. 2015; 7(1): 12-5.
Terashima SKM. Successful outcome of ALTA sclerotherapy in two pediatric cases. J. Jpn. Soc. Pediatr.. Surg. 2013; 49: 836.